Search Results

Summary Cross-reactivity with skeletal TnI is less than 10%.

Summary This antibody is specific for the approximately 95 kDa IR and shows no cross-reactivity with insulin like growth factor (IGF) receptors. Phosphorylation of the threonine residue within this sequence (corresponding to threonine 1348) decreases the affinity of this antibody for IR by approximately 100 fold. This antibody reacts with autophosphorylated IR, unoccupied IR, and the insulin IR complex. It has no effect on insulin-stimulated autophosphorylation.

Summary Reacts with free cardiac troponin I (cTnI). Reacts weakly with cTnI forming complexes with other troponin components.Not affected by phosphorylation. Recognizes an epitope located between amino acid residues 148 and 158 of cTnI. Nocross-reactivity with skeletal muscle troponin I.

Summary Prostate specific membrane antigen, extracellular domain. Reacts with human prostate carcinoma tissues andPSMA derived synthetic peptides. Does not react against normal human prostate tissues or to benignprostatic hyperplasia (BPH) tissues. Reactive to PSMA expressed LNCap cell lines.

Summary This antibody recognizes the long and short forms CD158a and CD158b (KIR2DL, KIR2DS1 and KIR2DS2 respectively) and also p50.3 (KIR2DS4).

Summary No cross-reactivity with skeletal muscle TnI.